Acurx Pharmaceuticals, Inc.
|
-1.15 USD
|
50.435%
|
Adaptive Biotechnologies Corporation
|
-1.56 USD
|
63.462%
|
IO Biotech, Inc.
|
-1.98 USD
|
71.212%
|
VYNE Therapeutics Inc.
|
-2.77 USD
|
79.422%
|
Organovo Holdings, Inc.
|
-1.60 USD
|
64.375%
|
TNF Pharmaceuticals, Inc.
|
-5.33 USD
|
89.306%
|
Lexaria Bioscience Corp.
|
-1.01 USD
|
43.564%
|
Tonix Pharmaceuticals Holding Corp.
|
-219.09 USD
|
99.74%
|
Aadi Bioscience, Inc.
|
-2.44 USD
|
76.639%
|
Savara Inc.
|
-0.33 USD
|
-72.727%
|
Aerovate Therapeutics, Inc.
|
-2.87 USD
|
80.139%
|
Rocket Pharmaceuticals, Inc.
|
-2.92 USD
|
80.479%
|
Corbus Pharmaceuticals Holdings, Inc.
|
-10.31 USD
|
94.471%
|
ZyVersa Therapeutics, Inc.
|
-1089.67 USD
|
99.948%
|
Soligenix, Inc.
|
-12.66 USD
|
95.498%
|
Aptose Biosciences Inc.
|
-7.58 USD
|
92.48%
|
NKGen Biotech, Inc. Common Stock
|
-5.38 USD
|
89.405%
|
Century Therapeutics, Inc.
|
-2.30 USD
|
75.217%
|
Eterna Therapeutics Inc.
|
-4.08 USD
|
86.029%
|
Precision BioSciences, Inc.
|
-15.96 USD
|
96.429%
|
Axsome Therapeutics, Inc.
|
-5.27 USD
|
89.184%
|
Kura Oncology, Inc.
|
-2.08 USD
|
72.596%
|
Xenetic Biosciences, Inc.
|
-2.71 USD
|
78.967%
|
Dyadic International, Inc.
|
-0.24 USD
|
-137.5%
|
TScan Therapeutics, Inc.
|
-1.36 USD
|
58.088%
|
IDEAYA Biosciences, Inc.
|
-1.96 USD
|
70.918%
|
CytomX Therapeutics, Inc.
|
-0.01 USD
|
-7302.597%
|
Autolus Therapeutics plc
|
-1.20 USD
|
52.5%
|
Eton Pharmaceuticals, Inc.
|
-0.04 USD
|
-1461.644%
|
EyePoint Pharmaceuticals, Inc.
|
-1.82 USD
|
68.681%
|
GRI Bio, Inc.
|
-28.25 USD
|
97.982%
|
Tenaya Therapeutics, Inc.
|
-1.68 USD
|
66.071%
|
IGM Biosciences, Inc.
|
-4.71 USD
|
87.898%
|
Heron Therapeutics, Inc.
|
-0.80 USD
|
28.75%
|
SAB Biotherapeutics, Inc.
|
-7.64 USD
|
92.539%
|
Entero Therapeutics, Inc.
|
-47.88 USD
|
98.81%
|
Opthea Limited
|
-0.35 USD
|
-62.857%
|
X4 Pharmaceuticals, Inc.
|
-0.57 USD
|
-0.0%
|
Atara Biotherapeutics, Inc.
|
-65.18 USD
|
99.125%
|
Pliant Therapeutics, Inc.
|
-2.75 USD
|
79.273%
|
Ligand Pharmaceuticals Incorporated
|
3.02 USD
|
118.874%
|
Surrozen, Inc.
|
-21.33 USD
|
97.328%
|
Lixte Biotechnology Holdings, Inc.
|
-2.66 USD
|
78.571%
|
Cingulate Inc.
|
-311.99 USD
|
99.817%
|
Ovid Therapeutics Inc.
|
-0.74 USD
|
22.973%
|
Sorrento Therapeutics, Inc.
|
-1.37 USD
|
58.394%
|
Acelyrin, Inc.
|
-5.43 USD
|
89.503%
|
Centessa Pharmaceuticals plc
|
-1.57 USD
|
63.694%
|
Hepion Pharmaceuticals, Inc.
|
-12.32 USD
|
95.373%
|
Arcturus Therapeutics Holdings Inc.
|
-1.12 USD
|
49.107%
|
Syros Pharmaceuticals, Inc.
|
-5.81 USD
|
90.189%
|
ADMA Biologics, Inc.
|
-0.13 USD
|
-338.462%
|
PureTech Health plc
|
-2.38 USD
|
76.05%
|
Oncternal Therapeutics, Inc.
|
-13.43 USD
|
95.756%
|
FibroBiologics, Inc. Common Stock
|
-0.59 USD
|
3.39%
|
Barinthus Biotherapeutics plc
|
-1.91 USD
|
70.157%
|
Kymera Therapeutics, Inc.
|
-2.52 USD
|
77.381%
|
Synaptogenix, Inc.
|
-29.56 USD
|
98.072%
|
Tiziana Life Sciences Ltd
|
-0.16 USD
|
-256.25%
|
ChromaDex Corporation
|
-0.07 USD
|
-764.947%
|
Inhibikase Therapeutics, Inc.
|
-3.57 USD
|
84.034%
|
Monopar Therapeutics Inc.
|
-0.58 USD
|
1.724%
|
Exelixis, Inc.
|
0.65 USD
|
187.692%
|
Akebia Therapeutics, Inc.
|
-0.28 USD
|
-103.571%
|
Better Therapeutics, Inc.
|
-1.69 USD
|
66.272%
|
Nurix Therapeutics, Inc.
|
-2.65 USD
|
78.491%
|
Apellis Pharmaceuticals, Inc.
|
-4.45 USD
|
87.191%
|
Sangamo Therapeutics, Inc.
|
-1.48 USD
|
61.486%
|
Seer, Inc.
|
-1.35 USD
|
57.778%
|
Aridis Pharmaceuticals, Inc.
|
-1.64 USD
|
65.244%
|
LAVA Therapeutics N.V.
|
-1.57 USD
|
63.694%
|
Gritstone bio, Inc.
|
-1.20 USD
|
52.5%
|
Jasper Therapeutics, Inc.
|
-6.18 USD
|
90.777%
|
Avid Bioservices, Inc.
|
-2.23 USD
|
74.439%
|
Insmed Incorporated
|
-5.34 USD
|
89.326%
|
Panbela Therapeutics, Inc.
|
-232.42 Thousand USD
|
100.0%
|
Avalo Therapeutics, Inc.
|
-113.58 USD
|
99.498%
|
Fate Therapeutics, Inc.
|
-1.64 USD
|
65.244%
|
MediWound Ltd.
|
-0.75 USD
|
24.0%
|
BioXcel Therapeutics, Inc.
|
-6.15 USD
|
90.732%
|
Fortress Biotech, Inc.
|
-8.47 USD
|
93.27%
|
OmniAb, Inc.
|
-0.51 USD
|
-11.765%
|
Seres Therapeutics, Inc.
|
-0.89 USD
|
35.955%
|
Zai Lab Limited
|
-3.46 USD
|
83.526%
|
Revance Therapeutics, Inc.
|
-3.83 USD
|
85.117%
|
Tarsus Pharmaceuticals, Inc.
|
-4.62 USD
|
87.662%
|
Veracyte, Inc.
|
-1.02 USD
|
44.118%
|
Abeona Therapeutics Inc.
|
-2.53 USD
|
77.47%
|
FibroGen, Inc.
|
-2.92 USD
|
80.479%
|
Apogee Therapeutics, Inc.
|
-0.00 USD
|
-16664.706%
|
ContextLogic Inc.
|
-13.36 USD
|
95.734%
|
Intensity Therapeutics, Inc.
|
-1.38 USD
|
58.696%
|
Adial Pharmaceuticals, Inc.
|
-5.44 USD
|
89.522%
|
HOOKIPA Pharma Inc.
|
-8.63 USD
|
93.395%
|
Jazz Pharmaceuticals plc
|
6.95 USD
|
108.201%
|
Entrada Therapeutics, Inc.
|
-0.20 USD
|
-185.0%
|
Cyclacel Pharmaceuticals, Inc.
|
-26.75 USD
|
97.869%
|
ImmuCell Corporation
|
-0.75 USD
|
24.0%
|
Fortrea Holdings Inc.
|
-0.04 USD
|
-1388.251%
|
KalVista Pharmaceuticals, Inc.
|
-3.44 USD
|
83.43%
|
Jasper Therapeutics, Inc.
|
-6.18 USD
|
90.777%
|
Foghorn Therapeutics Inc.
|
-2.34 USD
|
75.641%
|
Ultragenyx Pharmaceutical Inc.
|
-8.25 USD
|
93.091%
|
Theravance Biopharma, Inc.
|
-1.00 USD
|
43.0%
|
Metagenomi, Inc. Common Stock
|
-1.82 USD
|
68.681%
|
Vaxxinity, Inc.
|
-0.45 USD
|
-26.667%
|
BioCryst Pharmaceuticals, Inc.
|
-1.18 USD
|
51.695%
|
Gain Therapeutics, Inc.
|
-1.71 USD
|
66.667%
|
Creative Medical Technology Holdings, Inc.
|
-3.76 USD
|
84.84%
|
Marker Therapeutics, Inc.
|
-1.93 USD
|
70.466%
|
CASI Pharmaceuticals, Inc.
|
-2.02 USD
|
71.782%
|
Senti Biosciences, Inc.
|
-16.01 USD
|
96.44%
|
BioRestorative Therapies, Inc.
|
-2.47 USD
|
76.923%
|
Apollomics, Inc.
|
-2.32 USD
|
75.431%
|
89bio, Inc.
|
-2.00 USD
|
71.5%
|
Arrowhead Pharmaceuticals, Inc.
|
-1.91 USD
|
70.157%
|
TransCode Therapeutics, Inc.
|
-103.61 USD
|
99.45%
|
RAPT Therapeutics, Inc.
|
-3.05 USD
|
81.311%
|
Ardelyx, Inc.
|
-0.30 USD
|
-90.0%
|
Pluri Inc.
|
-3.99 USD
|
85.714%
|
Prothena Corporation plc
|
-2.76 USD
|
79.348%
|
Pulmatrix, Inc.
|
-3.87 USD
|
85.271%
|
Celularity Inc.
|
-11.02 USD
|
94.828%
|
MeiraGTx Holdings plc
|
-1.49 USD
|
61.745%
|
Omeros Corporation
|
-1.88 USD
|
69.681%
|
Ainos, Inc.
|
-3.36 USD
|
83.036%
|
Humacyte, Inc.
|
-1.07 USD
|
46.729%
|
Mesoblast Limited
|
-0.89 USD
|
35.955%
|
Cocrystal Pharma, Inc.
|
-1.86 USD
|
69.355%
|
Cidara Therapeutics, Inc.
|
-5.25 USD
|
89.143%
|
Blueprint Medicines Corporation
|
-8.37 USD
|
93.19%
|
Cabaletta Bio, Inc.
|
-1.65 USD
|
65.455%
|
Summit Therapeutics Inc.
|
-0.99 USD
|
42.424%
|
Alaunos Therapeutics, Inc.
|
-21.97 USD
|
97.406%
|
Scholar Rock Holding Corporation
|
-1.99 USD
|
71.357%
|
Intellia Therapeutics, Inc.
|
-5.42 USD
|
89.483%
|
Adlai Nortye Ltd. American Depositary Shares
|
-7.26 USD
|
92.149%
|
Cytokinetics, Incorporated
|
-5.45 USD
|
89.541%
|
Eloxx Pharmaceuticals, Inc.
|
-16.65 USD
|
96.577%
|
Nutriband Inc.
|
-0.69 USD
|
17.391%
|
Protara Therapeutics, Inc.
|
-3.57 USD
|
84.034%
|
Roivant Sciences Ltd.
|
5.55 USD
|
110.27%
|
Evogene Ltd.
|
-5.23 USD
|
89.101%
|
Applied Therapeutics, Inc.
|
-1.42 USD
|
59.859%
|
Hoth Therapeutics, Inc.
|
-2.30 USD
|
75.217%
|
BridgeBio Pharma, Inc.
|
-3.95 USD
|
85.57%
|
BioLineRx Ltd.
|
-0.94 USD
|
39.362%
|
Atai Life Sciences N.V.
|
-0.25 USD
|
-128.0%
|
VistaGen Therapeutics, Inc.
|
-1.52 USD
|
62.5%
|
Aurinia Pharmaceuticals Inc.
|
-0.54 USD
|
-5.556%
|
MediciNova, Inc.
|
-0.17 USD
|
-235.294%
|
Praxis Precision Medicines, Inc.
|
-18.69 USD
|
96.95%
|
MiMedx Group, Inc.
|
0.48 USD
|
218.75%
|
PTC Therapeutics, Inc.
|
-8.37 USD
|
93.19%
|
Cullinan Oncology, Inc.
|
-3.69 USD
|
84.553%
|
Syndax Pharmaceuticals, Inc.
|
-2.98 USD
|
80.872%
|
Pasithea Therapeutics Corp.
|
-12.65 USD
|
95.494%
|
NRx Pharmaceuticals, Inc.
|
-3.98 USD
|
85.678%
|
4D Molecular Therapeutics, Inc.
|
-2.58 USD
|
77.907%
|
Dyne Therapeutics, Inc.
|
-3.95 USD
|
85.57%
|
Kiniksa Pharmaceuticals, Ltd.
|
0.20 USD
|
385.0%
|
Ventyx Biosciences, Inc.
|
-3.30 USD
|
82.727%
|
Allakos Inc.
|
-2.14 USD
|
73.364%
|
Fulcrum Therapeutics, Inc.
|
-1.59 USD
|
64.151%
|
Corcept Therapeutics Incorporated
|
1.02 USD
|
155.882%
|
BioAtla, Inc.
|
-2.58 USD
|
77.907%
|
Allogene Therapeutics, Inc.
|
-2.09 USD
|
72.727%
|
Larimar Therapeutics, Inc.
|
-0.84 USD
|
32.143%
|
Precigen, Inc.
|
-0.39 USD
|
-46.154%
|
BriaCell Therapeutics Corp.
|
-0.29 USD
|
-96.552%
|
XOMA Corporation
|
-4.04 USD
|
85.891%
|
Kezar Life Sciences, Inc.
|
-1.40 USD
|
59.286%
|
Incyte Corporation
|
2.67 USD
|
121.348%
|
Cara Therapeutics, Inc.
|
-2.19 USD
|
73.973%
|
Aligos Therapeutics, Inc.
|
-3.52 USD
|
83.807%
|
Reviva Pharmaceuticals Holdings, Inc.
|
-1.25 USD
|
54.4%
|
CRISPR Therapeutics AG
|
-1.94 USD
|
70.619%
|
Akero Therapeutics, Inc.
|
-2.89 USD
|
80.277%
|
Eliem Therapeutics, Inc.
|
-1.30 USD
|
56.154%
|
EyeGate Pharmaceuticals, Inc.
|
-2.54 USD
|
77.559%
|
UroGen Pharma Ltd.
|
-3.55 USD
|
83.944%
|
Sutro Biopharma, Inc.
|
-1.78 USD
|
67.978%
|
ZIVO Bioscience, Inc.
|
-4.60 USD
|
87.609%
|
Lisata Therapeutics, Inc.
|
-2.58 USD
|
77.907%
|
Stoke Therapeutics, Inc.
|
-2.38 USD
|
76.05%
|
Chimerix, Inc.
|
-0.93 USD
|
38.71%
|
Outlook Therapeutics, Inc.
|
-4.72 USD
|
87.924%
|
60 Degrees Pharmaceuticals, Inc.
|
-0.95 USD
|
40.0%
|
Enanta Pharmaceuticals, Inc.
|
-6.38 USD
|
91.066%
|
Aprea Therapeutics, Inc.
|
-3.95 USD
|
85.57%
|
Portage Biotech Inc.
|
-3.70 USD
|
84.595%
|
OncoCyte Corporation
|
-3.75 USD
|
84.8%
|
Qualigen Therapeutics, Inc.
|
-2.46 USD
|
76.829%
|
Cadrenal Therapeutics, Inc. Common Stock
|
-0.62 USD
|
8.065%
|
Processa Pharmaceuticals, Inc.
|
-8.48 USD
|
93.278%
|
Purple Biotech Ltd.
|
-0.09 USD
|
-534.744%
|
NextCure, Inc.
|
-2.25 USD
|
74.667%
|
ProMIS Neurosciences, Inc.
|
-1.42 USD
|
59.859%
|
Dermata Therapeutics, Inc.
|
-40.18 USD
|
98.581%
|
Generation Bio Co.
|
-1.96 USD
|
70.918%
|
Neumora Therapeutics, Inc. Common Stock
|
-1.49 USD
|
61.745%
|
Xeris Biopharma Holdings, Inc.
|
-0.45 USD
|
-26.667%
|
TRACON Pharmaceuticals, Inc.
|
-2.20 USD
|
74.091%
|
NLS Pharmaceutics AG
|
-0.32 USD
|
-78.125%
|
Mineralys Therapeutics, Inc.
|
-1.99 USD
|
71.357%
|
Novavax, Inc.
|
-5.41 USD
|
89.464%
|
Virios Therapeutics, Inc.
|
-0.28 USD
|
-103.571%
|
Curis, Inc.
|
-8.96 USD
|
93.638%
|
Daré Bioscience, Inc.
|
-4.15 USD
|
86.265%
|
Titan Pharmaceuticals, Inc.
|
-7.41 USD
|
92.308%
|
Virpax Pharmaceuticals, Inc.
|
-12.97 USD
|
95.605%
|
Bicycle Therapeutics plc
|
-5.08 USD
|
88.78%
|
BeiGene, Ltd.
|
-8.45 USD
|
93.254%
|
Kiromic BioPharma, Inc.
|
-21.41 USD
|
97.338%
|
Alector, Inc.
|
-1.56 USD
|
63.462%
|
Protagonist Therapeutics, Inc.
|
-1.39 USD
|
58.993%
|
Erasca, Inc.
|
-0.83 USD
|
31.325%
|
Checkpoint Therapeutics, Inc.
|
-2.77 USD
|
79.422%
|
Aura Biosciences, Inc.
|
-1.93 USD
|
70.466%
|
Viracta Therapeutics, Inc.
|
-1.32 USD
|
56.818%
|
Chemomab Therapeutics Ltd.
|
-2.06 USD
|
72.33%
|
Protagenic Therapeutics, Inc.
|
-1.15 USD
|
50.435%
|
Pieris Pharmaceuticals, Inc.
|
-21.80 USD
|
97.385%
|
BioMarin Pharmaceutical Inc.
|
0.89 USD
|
164.045%
|
Histogen Inc.
|
-3.46 USD
|
83.526%
|
Fortress Biotech, Inc.
|
-8.47 USD
|
93.27%
|
Avidity Biosciences, Inc.
|
-2.91 USD
|
80.412%
|
Lyell Immunopharma, Inc.
|
-0.93 USD
|
38.71%
|
Galecto, Inc.
|
-36.08 USD
|
98.42%
|
InMed Pharmaceuticals Inc.
|
-1.01 USD
|
43.564%
|
Phathom Pharmaceuticals, Inc.
|
-3.93 USD
|
85.496%
|
Molecular Templates, Inc.
|
-1.80 USD
|
68.333%
|
PDS Biotechnology Corporation
|
-1.39 USD
|
58.993%
|
Amylyx Pharmaceuticals, Inc.
|
0.73 USD
|
178.082%
|
Amarin Corporation plc
|
-0.15 USD
|
-280.0%
|
TG Therapeutics, Inc.
|
0.09 USD
|
738.298%
|
Aptevo Therapeutics Inc.
|
-62.62 USD
|
99.09%
|
Celldex Therapeutics, Inc.
|
-2.92 USD
|
80.479%
|
Cogent Biosciences, Inc.
|
-2.42 USD
|
76.446%
|
Onconetix, Inc.
|
-2.19 USD
|
73.973%
|
MacroGenics, Inc.
|
-0.15 USD
|
-280.0%
|
Y-mAbs Therapeutics, Inc.
|
-0.49 USD
|
-16.327%
|
Ocuphire Pharma, Inc.
|
-0.46 USD
|
-23.913%
|
Adagene Inc.
|
-0.44 USD
|
-29.545%
|
Inhibrx Biosciences, Inc.
|
-5.12 USD
|
88.867%
|
Cartesian Therapeutics, Inc.
|
-42.49 USD
|
98.659%
|
Voyager Therapeutics, Inc.
|
3.08 USD
|
118.506%
|
SciSparc Ltd.
|
-14.43 USD
|
96.05%
|
Revelation Biosciences, Inc.
|
-0.53 USD
|
-7.547%
|
Minerva Neurosciences, Inc.
|
-4.61 USD
|
87.636%
|
Astria Therapeutics, Inc.
|
-2.42 USD
|
76.446%
|
Black Diamond Therapeutics, Inc.
|
-1.88 USD
|
69.681%
|
Arcutis Biotherapeutics, Inc.
|
-3.78 USD
|
84.921%
|
Relay Therapeutics, Inc.
|
-2.79 USD
|
79.57%
|
Alnylam Pharmaceuticals, Inc.
|
-3.52 USD
|
83.807%
|
Psyence Biomedical Ltd.
|
-7.85 USD
|
92.739%
|
Artelo Biosciences, Inc.
|
-3.49 USD
|
83.668%
|
2seventy bio, Inc.
|
-4.42 USD
|
87.104%
|
Clene Inc.
|
-9.43 USD
|
93.955%
|
Boundless Bio, Inc. Common Stock
|
-2.22 USD
|
74.324%
|
GeoVax Labs, Inc.
|
-10.22 USD
|
94.423%
|
Sonnet BioTherapeutics Holdings, Inc.
|
-18.14 USD
|
96.858%
|
Arbutus Biopharma Corporation
|
-0.44 USD
|
-29.545%
|
Scopus BioPharma Inc.
|
-0.55 USD
|
-3.636%
|
Absci Corporation
|
-1.20 USD
|
52.5%
|
XBiotech Inc.
|
-0.81 USD
|
29.63%
|
ALX Oncology Holdings Inc.
|
-3.74 USD
|
84.759%
|
Lyra Therapeutics, Inc.
|
-1.26 USD
|
54.762%
|
Entera Bio Ltd.
|
-0.31 USD
|
-83.871%
|
Trevena, Inc.
|
-54.51 USD
|
98.954%
|
Adaptimmune Therapeutics plc
|
-0.57 USD
|
-0.0%
|
Caribou Biosciences, Inc.
|
-1.38 USD
|
58.696%
|
INmune Bio, Inc.
|
-1.67 USD
|
65.868%
|
Citius Pharmaceuticals, Inc.
|
-0.22 USD
|
-159.091%
|
Tyra Biosciences, Inc.
|
-1.62 USD
|
64.815%
|
Galmed Pharmaceuticals Ltd.
|
-30.05 USD
|
98.103%
|
Unity Biotechnology, Inc.
|
-2.70 USD
|
78.889%
|
Tenax Therapeutics, Inc.
|
-31.09 USD
|
98.167%
|
Jaguar Health, Inc.
|
-107.42 USD
|
99.469%
|
Clearside Biomedical, Inc.
|
-0.53 USD
|
-7.547%
|
NexImmune, Inc.
|
-30.82 USD
|
98.151%
|
Connect Biopharma Holdings Limited
|
-1.08 USD
|
47.222%
|
Clearmind Medicine Inc.
|
-59.18 USD
|
99.037%
|
Coeptis Therapeutics Holdings, Inc.
|
-0.83 USD
|
31.325%
|
Kronos Bio, Inc.
|
-1.95 USD
|
70.769%
|
Innoviva, Inc.
|
2.92 USD
|
119.521%
|
Coherus BioSciences, Inc.
|
-2.53 USD
|
77.47%
|
Regeneron Pharmaceuticals, Inc.
|
37.05 USD
|
101.538%
|
Bolt Biotherapeutics, Inc.
|
-1.83 USD
|
68.852%
|
Verastem, Inc.
|
-3.96 USD
|
85.606%
|
ProKidney Corp.
|
-0.57 USD
|
-0.0%
|
CERo Therapeutics Holdings, Inc.
|
-0.39 USD
|
-46.154%
|
Imunon, Inc.
|
-2.16 USD
|
73.611%
|
Viking Therapeutics, Inc.
|
-0.91 USD
|
37.363%
|
Statera Biopharma, Inc.
|
-4.97 USD
|
88.531%
|
ImmunityBio, Inc.
|
-1.15 USD
|
50.435%
|
Korro Bio, Inc.
|
-53.08 USD
|
98.926%
|
Travere Therapeutics, Inc.
|
-1.50 USD
|
62.0%
|
Kineta, Inc.
|
-1.28 USD
|
55.469%
|
Catalyst Pharmaceuticals, Inc.
|
0.67 USD
|
185.075%
|
Capricor Therapeutics, Inc.
|
-0.83 USD
|
31.325%
|
GT Biopharma, Inc.
|
-5.64 USD
|
89.894%
|
Keros Therapeutics, Inc.
|
-5.20 USD
|
89.038%
|
Celularity Inc.
|
-11.02 USD
|
94.828%
|
Crinetics Pharmaceuticals, Inc.
|
-3.69 USD
|
84.553%
|
CalciMedica, Inc.
|
-7.65 USD
|
92.549%
|
Cibus, Inc.
|
-25.95 USD
|
97.803%
|
C4 Therapeutics, Inc.
|
-2.67 USD
|
78.652%
|
Marinus Pharmaceuticals, Inc.
|
-2.63 USD
|
78.327%
|
Eledon Pharmaceuticals, Inc.
|
-0.00 USD
|
-35525.0%
|
Kodiak Sciences Inc.
|
-4.97 USD
|
88.531%
|
Sana Biotechnology, Inc.
|
-1.46 USD
|
60.959%
|
Annexon, Inc.
|
-1.77 USD
|
67.797%
|
Adverum Biotechnologies, Inc.
|
-11.62 USD
|
95.095%
|
Assembly Biosciences, Inc.
|
-13.38 USD
|
95.74%
|
Elicio Therapeutics, Inc.
|
-6.96 USD
|
91.81%
|
Moderna, Inc.
|
-12.34 USD
|
95.381%
|
Vigil Neuroscience, Inc.
|
-2.13 USD
|
73.239%
|
Ionis Pharmaceuticals, Inc.
|
-2.56 USD
|
77.734%
|
Vor Biopharma Inc.
|
-1.75 USD
|
67.429%
|
Eyenovia, Inc.
|
-0.66 USD
|
13.636%
|
DiaMedica Therapeutics Inc.
|
-0.60 USD
|
5.0%
|
Puma Biotechnology, Inc.
|
0.46 USD
|
223.913%
|
Monte Rosa Therapeutics, Inc.
|
-2.63 USD
|
78.327%
|
Wave Life Sciences Ltd.
|
-0.54 USD
|
-5.556%
|
Conduit Pharmaceuticals Inc.
|
-0.09 USD
|
-530.531%
|
ACADIA Pharmaceuticals Inc.
|
-0.37 USD
|
-54.054%
|
Immunocore Holdings plc
|
-1.13 USD
|
49.558%
|
Tango Therapeutics, Inc.
|
-1.08 USD
|
47.222%
|
Galectin Therapeutics Inc.
|
-0.74 USD
|
22.973%
|
Alkermes plc
|
2.14 USD
|
126.636%
|
Arcellx, Inc.
|
-1.47 USD
|
61.224%
|
Renovaro Biosciences Inc.
|
-0.84 USD
|
32.143%
|
Zentalis Pharmaceuticals, Inc.
|
-4.47 USD
|
87.248%
|
Sagimet Biosciences Inc.
|
-2.66 USD
|
78.571%
|
Regulus Therapeutics Inc.
|
-1.58 USD
|
63.924%
|
Cardio Diagnostics Holdings, Inc.
|
-0.66 USD
|
13.636%
|
Moolec Science SA
|
-1.50 USD
|
62.0%
|
Biomea Fusion, Inc.
|
-3.44 USD
|
83.43%
|
RenovoRx, Inc.
|
-0.99 USD
|
42.424%
|
Geron Corporation
|
-0.32 USD
|
-78.125%
|
Mereo BioPharma Group plc
|
-0.04 USD
|
-1175.168%
|
Verrica Pharmaceuticals Inc.
|
-1.48 USD
|
61.486%
|
Royalty Pharma plc
|
3.41 USD
|
116.716%
|
Atea Pharmaceuticals, Inc.
|
-1.63 USD
|
65.031%
|
Greenwich LifeSciences, Inc.
|
-0.69 USD
|
17.391%
|
Calithera Biosciences, Inc.
|
-7.94 USD
|
92.821%
|
TFF Pharmaceuticals, Inc.
|
-11.85 USD
|
95.19%
|
Mersana Therapeutics, Inc.
|
-1.48 USD
|
61.486%
|
Humacyte, Inc.
|
-1.07 USD
|
46.729%
|
Structure Therapeutics Inc.
|
-2.44 USD
|
76.639%
|
NLS Pharmaceutics AG
|
-0.32 USD
|
-78.125%
|
Genelux Corporation
|
-1.16 USD
|
50.862%
|
ESSA Pharma Inc.
|
-0.60 USD
|
5.0%
|
aTyr Pharma, Inc.
|
-0.94 USD
|
39.362%
|
Notable Labs, Ltd.
|
-5.03 USD
|
88.668%
|
Alzamend Neuro, Inc.
|
-14.72 USD
|
96.128%
|
Mustang Bio, Inc.
|
-6.00 USD
|
90.5%
|
Immunovant, Inc.
|
-1.88 USD
|
69.681%
|
Tevogen Bio Holdings Inc.
|
-0.00 USD
|
-142400.0%
|
Vericel Corporation
|
-0.07 USD
|
-752.018%
|
Halozyme Therapeutics, Inc.
|
2.13 USD
|
126.761%
|
Akari Therapeutics, Plc
|
-2.04 USD
|
72.059%
|
Acasti Pharma Inc.
|
-1.35 USD
|
57.778%
|
MiNK Therapeutics, Inc.
|
-0.65 USD
|
12.308%
|
Vaxcyte, Inc.
|
-4.14 USD
|
86.232%
|
Orgenesis Inc.
|
-1.91 USD
|
70.157%
|
Spruce Biosciences, Inc.
|
-1.24 USD
|
54.032%
|
NeuroBo Pharmaceuticals, Inc.
|
-2.46 USD
|
76.829%
|
GH Research PLC
|
-0.68 USD
|
16.176%
|
Tempest Therapeutics, Inc.
|
-1.91 USD
|
70.157%
|
PepGen Inc.
|
-3.30 USD
|
82.727%
|
Moleculin Biotech, Inc.
|
-15.07 USD
|
96.218%
|
Relmada Therapeutics, Inc.
|
-3.28 USD
|
82.622%
|
BriaCell Therapeutics Corp.
|
-0.29 USD
|
-96.552%
|
Lixte Biotechnology Holdings, Inc.
|
-2.66 USD
|
78.571%
|
Silo Pharma, Inc.
|
-1.20 USD
|
52.5%
|
Telomir Pharmaceuticals, Inc. Common Stock
|
-0.44 USD
|
-29.545%
|
Belite Bio, Inc
|
-1.19 USD
|
52.101%
|
Pharming Group N.V.
|
-0.16 USD
|
-256.25%
|
XOMA Corporation
|
-4.04 USD
|
85.891%
|
Reneo Pharmaceuticals, Inc.
|
-25.23 USD
|
97.741%
|
Reviva Pharmaceuticals Holdings, Inc.
|
-1.25 USD
|
54.4%
|
Bionomics Limited
|
-1.02 USD
|
44.118%
|
Xencor, Inc.
|
-2.08 USD
|
72.596%
|
Replimune Group, Inc.
|
-3.24 USD
|
82.407%
|
Pyxis Oncology, Inc.
|
-1.85 USD
|
69.189%
|
Cassava Sciences, Inc.
|
-2.32 USD
|
75.431%
|
Vanda Pharmaceuticals Inc.
|
0.04 USD
|
1404.348%
|
Estrella Immunopharma, Inc.
|
-0.21 USD
|
-171.429%
|
Turnstone Biologics Corp.
|
-4.77 USD
|
88.05%
|
Windtree Therapeutics, Inc.
|
-92.23 USD
|
99.382%
|
GeoVax Labs, Inc.
|
-10.22 USD
|
94.423%
|
MEI Pharma, Inc.
|
2.67 USD
|
121.348%
|
Olema Pharmaceuticals, Inc.
|
-2.14 USD
|
73.364%
|
Cardio Diagnostics Holdings, Inc.
|
-0.66 USD
|
13.636%
|
Bio-Path Holdings, Inc.
|
-33.64 USD
|
98.306%
|
Enlivex Therapeutics Ltd.
|
-1.56 USD
|
63.462%
|
CollPlant Biotechnologies Ltd.
|
-0.62 USD
|
8.065%
|
scPharmaceuticals Inc.
|
-1.42 USD
|
59.859%
|
HilleVax, Inc.
|
-3.04 USD
|
81.25%
|
Vera Therapeutics, Inc.
|
-2.25 USD
|
74.667%
|
Tharimmune, Inc.
|
-107.08 USD
|
99.468%
|
Genprex, Inc.
|
-22.58 USD
|
97.476%
|
SeaStar Medical Holding Corporation
|
-30.29 USD
|
98.118%
|
Immunic, Inc.
|
-2.11 USD
|
72.986%
|
Atossa Therapeutics, Inc.
|
-0.24 USD
|
-137.5%
|
Aptorum Group Limited
|
-0.62 USD
|
8.065%
|
Soleno Therapeutics, Inc.
|
-2.36 USD
|
75.847%
|
SeaStar Medical Holding Corporation
|
-30.29 USD
|
98.118%
|
OKYO Pharma Limited
|
-0.00 USD
|
-94900.0%
|
Carmell Therapeutics Corporation
|
-1.46 USD
|
60.959%
|
Achieve Life Sciences, Inc.
|
-1.50 USD
|
62.0%
|
Ocean Biomedical, Inc.
|
-0.03 USD
|
-2067.3%
|
Amicus Therapeutics, Inc.
|
-0.51 USD
|
-11.765%
|
Salarius Pharmaceuticals, Inc.
|
-0.00 USD
|
-14900.0%
|
bluebird bio, Inc.
|
-1.93 USD
|
70.466%
|
DBV Technologies S.A.
|
-0.76 USD
|
25.0%
|
Compugen Ltd.
|
-0.21 USD
|
-171.429%
|
Protagenic Therapeutics, Inc.
|
-1.15 USD
|
50.435%
|
Peak Bio, Inc.
|
- USD
|
Infinity%
|
Vincerx Pharma, Inc.
|
-1.89 USD
|
69.841%
|
Fresh Tracks Therapeutics, Inc.
|
-0.96 USD
|
40.625%
|
Sensei Biotherapeutics, Inc.
|
-1.22 USD
|
53.279%
|
Orchestra BioMed Holdings, Inc.
|
-1.48 USD
|
61.486%
|
Zevra Therapeutics, Inc.
|
-1.30 USD
|
56.154%
|
Acrivon Therapeutics, Inc. Common Stock
|
-2.74 USD
|
79.197%
|
Benitec Biopharma Inc.
|
-5.36 USD
|
89.366%
|
Spyre Therapeutics, Inc.
|
-49.12 USD
|
98.84%
|
Adicet Bio, Inc.
|
-3.31 USD
|
82.779%
|
Prime Medicine, Inc.
|
-2.18 USD
|
73.853%
|
Aditxt, Inc.
|
-4326.64 USD
|
99.987%
|
Madrigal Pharmaceuticals, Inc.
|
-19.99 USD
|
97.149%
|
Estrella Immunopharma, Inc.
|
-0.21 USD
|
-171.429%
|
Quantum-Si incorporated
|
-0.68 USD
|
16.176%
|
GlycoMimetics, Inc.
|
-0.58 USD
|
1.724%
|
PolyPid Ltd.
|
-16.99 USD
|
96.645%
|
Aileron Therapeutics, Inc.
|
-3.42 USD
|
83.333%
|
Invivyd, Inc.
|
-1.81 USD
|
68.508%
|
Quoin Pharmaceuticals, Ltd.
|
-9.64 USD
|
94.087%
|
Rigel Pharmaceuticals, Inc.
|
-1.44 USD
|
60.417%
|
CorMedix Inc.
|
-0.91 USD
|
37.363%
|
Instil Bio, Inc.
|
-24.00 USD
|
97.625%
|
Recursion Pharmaceuticals, Inc.
|
-1.58 USD
|
63.924%
|
Contineum Therapeutics, Inc. Class A Common Stock
|
1.36 USD
|
141.912%
|
Finch Therapeutics Group, Inc.
|
-46.59 USD
|
98.777%
|
Spero Therapeutics, Inc.
|
0.43 USD
|
232.558%
|
Alpha Tau Medical Ltd.
|
-0.42 USD
|
-35.714%
|
AbCellera Biologics Inc.
|
-0.51 USD
|
-11.765%
|
Ocular Therapeutix, Inc.
|
-1.09 USD
|
47.706%
|
Surrozen, Inc.
|
-21.33 USD
|
97.328%
|
Janux Therapeutics, Inc.
|
-1.32 USD
|
56.818%
|
Verona Pharma plc
|
-0.54 USD
|
-5.556%
|
Terns Pharmaceuticals, Inc.
|
-1.27 USD
|
55.118%
|
Vir Biotechnology, Inc.
|
-4.59 USD
|
87.582%
|
Evaxion Biotech A/S
|
-8.11 USD
|
92.972%
|
Verve Therapeutics, Inc.
|
-3.12 USD
|
81.731%
|
Shattuck Labs, Inc.
|
-2.05 USD
|
72.195%
|
AlloVir, Inc.
|
-1.83 USD
|
68.852%
|
BioVie Inc.
|
-7.30 USD
|
92.192%
|
Codexis, Inc.
|
-1.12 USD
|
49.107%
|
SELLAS Life Sciences Group, Inc.
|
-1.34 USD
|
57.463%
|
Lexaria Bioscience Corp.
|
-1.01 USD
|
43.564%
|
Agenus Inc.
|
-13.75 USD
|
95.855%
|
Virax Biolabs Group Limited
|
-3.36 USD
|
83.036%
|
Lantern Pharma Inc.
|
-1.47 USD
|
61.224%
|
Viridian Therapeutics, Inc.
|
-5.31 USD
|
89.266%
|
eFFECTOR Therapeutics, Inc.
|
-16.37 USD
|
96.518%
|
Immix Biopharma, Inc.
|
-0.89 USD
|
35.955%
|
Celcuity Inc.
|
-2.69 USD
|
78.81%
|
Cardiff Oncology, Inc.
|
-0.93 USD
|
38.71%
|
Acumen Pharmaceuticals, Inc.
|
-1.08 USD
|
47.222%
|
IN8bio, Inc.
|
-1.00 USD
|
43.0%
|
Avenue Therapeutics, Inc.
|
-73.60 USD
|
99.226%
|
Trevi Therapeutics, Inc.
|
-0.29 USD
|
-96.552%
|
Lexicon Pharmaceuticals, Inc.
|
-0.80 USD
|
28.75%
|
Liquidia Corporation
|
-1.21 USD
|
52.893%
|
Quantum-Si incorporated
|
-0.68 USD
|
16.176%
|
Pasithea Therapeutics Corp.
|
-12.65 USD
|
95.494%
|
Xenon Pharmaceuticals Inc.
|
-2.73 USD
|
79.121%
|
Sol-Gel Technologies Ltd.
|
-1.01 USD
|
43.564%
|
United Therapeutics Corporation
|
21.04 USD
|
102.709%
|
Solid Biosciences Inc.
|
-4.83 USD
|
88.199%
|
Immuneering Corporation
|
-1.88 USD
|
69.681%
|
Alpha Tau Medical Ltd.
|
-0.42 USD
|
-35.714%
|
uniQure N.V.
|
-6.47 USD
|
91.19%
|
Xilio Therapeutics, Inc.
|
-2.78 USD
|
79.496%
|
Enveric Biosciences, Inc.
|
-8.09 USD
|
92.954%
|
Poseida Therapeutics, Inc.
|
-1.37 USD
|
58.394%
|
Longboard Pharmaceuticals, Inc.
|
-2.39 USD
|
76.151%
|
PMV Pharmaceuticals, Inc.
|
-1.44 USD
|
60.417%
|
Elevai Labs, Inc. Common Stock
|
-0.40 USD
|
-42.5%
|
Cue Biopharma, Inc.
|
-1.11 USD
|
48.649%
|
Nuvectis Pharma, Inc.
|
-1.43 USD
|
60.14%
|
Zura Bio Limited
|
-2.09 USD
|
72.727%
|
Forte Biosciences, Inc.
|
-24.92 USD
|
97.713%
|
Elevation Oncology, Inc.
|
-1.34 USD
|
57.463%
|
Conduit Pharmaceuticals Inc.
|
-0.09 USD
|
-530.531%
|
Immunome, Inc.
|
-5.38 USD
|
89.405%
|
Compass Therapeutics, Inc.
|
-0.33 USD
|
-72.727%
|
enGene Holdings Inc. Warrants
|
-4.51 USD
|
87.361%
|
Inovio Pharmaceuticals, Inc.
|
-6.09 USD
|
90.64%
|
LENZ Therapeutics, Inc.
|
-15.30 USD
|
96.275%
|
Altimmune, Inc.
|
-1.66 USD
|
65.663%
|
Milestone Pharmaceuticals Inc.
|
-1.39 USD
|
58.993%
|
Rallybio Corporation
|
-1.84 USD
|
69.022%
|
Plus Therapeutics, Inc.
|
-4.24 USD
|
86.557%
|
Dianthus Therapeutics, Inc.
|
-8.45 USD
|
93.254%
|
Moolec Science SA
|
-1.50 USD
|
62.0%
|
Anebulo Pharmaceuticals, Inc.
|
-0.32 USD
|
-78.125%
|
XTL Biopharmaceuticals Ltd.
|
-0.00 USD
|
-17172.727%
|
Tourmaline Bio, Inc.
|
-8.87 USD
|
93.574%
|
NeurAxis, Inc.
|
-4.03 USD
|
85.856%
|
Maravai LifeSciences Holdings, Inc.
|
-0.90 USD
|
36.667%
|
Lumos Pharma, Inc.
|
-4.18 USD
|
86.364%
|
enGene Holdings Inc. Common Stock
|
-4.51 USD
|
87.361%
|
180 Life Sciences Corp.
|
-52.60 USD
|
98.916%
|
NKGen Biotech, Inc. Warrants
|
-5.38 USD
|
89.405%
|
Opiant Pharmaceuticals, Inc.
|
0.68 USD
|
183.824%
|
CERo Therapeutics Holdings, Inc.
|
-0.39 USD
|
-46.154%
|
Nutriband Inc.
|
-0.69 USD
|
17.391%
|
CG Oncology, Inc. Common stock
|
-15.65 USD
|
96.358%
|
argenx SE
|
-5.16 USD
|
88.953%
|
Neurogene Inc.
|
-2.83 USD
|
79.859%
|
Mirum Pharmaceuticals, Inc.
|
-4.00 USD
|
85.75%
|
Kintara Therapeutics, Inc.
|
-3.23 USD
|
82.353%
|
CervoMed Inc.
|
-0.82 USD
|
30.488%
|
CARGO Therapeutics, Inc. Common Stock
|
-2.38 USD
|
76.05%
|
Sesen Bio, Inc.
|
-1.99 USD
|
71.357%
|
AnaptysBio, Inc.
|
-6.08 USD
|
90.625%
|
Design Therapeutics, Inc.
|
-1.19 USD
|
52.101%
|
Leap Therapeutics, Inc.
|
-3.98 USD
|
85.678%
|
Seelos Therapeutics, Inc.
|
-7.73 USD
|
92.626%
|
Achilles Therapeutics plc
|
-1.74 USD
|
67.241%
|
NeuroSense Therapeutics Ltd.
|
-0.83 USD
|
31.325%
|
ORIC Pharmaceuticals, Inc.
|
-1.96 USD
|
70.918%
|
Fractyl Health, Inc. Common Stock
|
-1.98 USD
|
71.212%
|
Rani Therapeutics Holdings, Inc.
|
-1.33 USD
|
57.143%
|
MoonLake Immunotherapeutics
|
-0.73 USD
|
21.918%
|
Palisade Bio, Inc.
|
-27.01 USD
|
97.89%
|
Beam Therapeutics Inc.
|
-1.72 USD
|
66.86%
|
AEON Biopharma, Inc.
|
- USD
|
Infinity%
|
Enliven Therapeutics, Inc.
|
-2.01 USD
|
71.642%
|
Kiora Pharmaceuticals, Inc.
|
-24.25 USD
|
97.649%
|
Iovance Biotherapeutics, Inc.
|
-1.89 USD
|
69.841%
|
Taysha Gene Therapies, Inc.
|
-0.96 USD
|
40.625%
|
Athira Pharma, Inc.
|
-3.10 USD
|
81.613%
|
Vaccinex, Inc.
|
-43.68 USD
|
98.695%
|
HCW Biologics Inc.
|
-0.70 USD
|
18.571%
|
XOMA Corporation
|
-4.04 USD
|
85.891%
|
Nektar Therapeutics
|
-1.45 USD
|
60.69%
|
Arvinas, Inc.
|
-6.62 USD
|
91.39%
|
Tevogen Bio Holdings Inc.
|
-0.00 USD
|
-142400.0%
|
Merus N.V.
|
-3.00 USD
|
81.0%
|
Omega Therapeutics, Inc.
|
-1.80 USD
|
68.333%
|
Quince Therapeutics, Inc.
|
-0.84 USD
|
32.143%
|
Rezolute, Inc.
|
-1.33 USD
|
57.143%
|
Clene Inc.
|
-9.43 USD
|
93.955%
|
Indaptus Therapeutics, Inc.
|
-1.84 USD
|
69.022%
|
BeyondSpring Inc.
|
-0.54 USD
|
-5.556%
|
Synlogic, Inc.
|
-8.81 USD
|
93.53%
|
Allarity Therapeutics, Inc.
|
-0.01 USD
|
-5433.981%
|
Phio Pharmaceuticals Corp.
|
-46.87 USD
|
98.784%
|
Peak Bio, Inc.
|
- USD
|
Infinity%
|
Werewolf Therapeutics, Inc.
|
-1.05 USD
|
45.714%
|
Krystal Biotech, Inc.
|
0.40 USD
|
242.5%
|
Karyopharm Therapeutics Inc.
|
-1.25 USD
|
54.4%
|
SpringWorks Therapeutics, Inc.
|
-5.15 USD
|
88.932%
|
Lipella Pharmaceuticals Inc.
|
-0.77 USD
|
25.974%
|
MannKind Corporation
|
-0.04 USD
|
-1175.168%
|
Ikena Oncology, Inc.
|
-1.63 USD
|
65.031%
|
Cyclerion Therapeutics, Inc.
|
-8.99 USD
|
93.66%
|
Gyre Therapeutics, Inc.
|
-1.41 USD
|
59.574%
|
Gossamer Bio, Inc.
|
-1.18 USD
|
51.695%
|
CohBar, Inc.
|
-4.13 USD
|
86.199%
|
Cognition Therapeutics, Inc.
|
-0.86 USD
|
33.721%
|
NRx Pharmaceuticals, Inc.
|
-3.98 USD
|
85.678%
|
Legend Biotech Corporation
|
-2.94 USD
|
80.612%
|
Mural Oncology plc
|
-12.43 USD
|
95.414%
|
Biora Therapeutics, Inc.
|
-7.87 USD
|
92.757%
|
PaxMedica, Inc. Common Stock
|
-11.00 USD
|
94.818%
|
Disc Medicine, Inc.
|
-3.43 USD
|
83.382%
|
Champions Oncology, Inc.
|
-0.54 USD
|
-5.556%
|
REGENXBIO Inc.
|
-6.02 USD
|
90.532%
|
Ensysce Biosciences, Inc.
|
-4.69 USD
|
87.846%
|
Anavex Life Sciences Corp.
|
-0.60 USD
|
5.0%
|
Cellectar Biosciences, Inc.
|
-3.11 USD
|
81.672%
|
Edgewise Therapeutics, Inc.
|
-1.57 USD
|
63.694%
|
Vaxart, Inc.
|
-0.57 USD
|
-0.0%
|
PharmaCyte Biotech, Inc.
|
-1.80 USD
|
68.333%
|
Aldeyra Therapeutics, Inc.
|
-0.64 USD
|
10.938%
|
Cellectis S.A.
|
-1.77 USD
|
67.797%
|
Longeveron Inc.
|
-10.22 USD
|
94.423%
|
Repare Therapeutics Inc.
|
-2.23 USD
|
74.439%
|
Sarepta Therapeutics, Inc.
|
-5.80 USD
|
90.172%
|
Inozyme Pharma, Inc.
|
-1.37 USD
|
58.394%
|
Revolution Medicines, Inc.
|
-3.86 USD
|
85.233%
|
Nymox Pharmaceutical Corporation
|
-0.07 USD
|
-675.51%
|
Third Harmonic Bio, Inc.
|
-0.78 USD
|
26.923%
|
ArriVent BioPharma, Inc. Common Stock
|
-2.17 USD
|
73.733%
|
AN2 Therapeutics, Inc.
|
-2.74 USD
|
79.197%
|
Anixa Biosciences, Inc.
|
-0.32 USD
|
-78.125%
|
Vertex Pharmaceuticals Incorporated
|
14.05 USD
|
104.057%
|
Denali Therapeutics Inc.
|
-1.06 USD
|
46.226%
|
Revelation Biosciences, Inc.
|
-0.53 USD
|
-7.547%
|
Veru Inc.
|
-1.10 USD
|
48.182%
|
Corvus Pharmaceuticals, Inc.
|
-0.56 USD
|
-1.786%
|
Cingulate Inc.
|
-311.99 USD
|
99.817%
|
Passage Bio, Inc.
|
-1.86 USD
|
69.355%
|
Context Therapeutics Inc.
|
-1.50 USD
|
62.0%
|
Exicure, Inc.
|
-2.11 USD
|
72.986%
|
Day One Biopharmaceuticals, Inc.
|
-2.37 USD
|
75.949%
|
Oramed Pharmaceuticals Inc.
|
-0.97 USD
|
41.237%
|
Revolution Medicines, Inc. Warrant
|
-3.86 USD
|
85.233%
|
Scinai Immunotherapeutics Ltd.
|
-16.62 USD
|
96.57%
|
Rhythm Pharmaceuticals, Inc.
|
-3.20 USD
|
82.188%
|
Nuvalent, Inc.
|
-2.17 USD
|
73.733%
|
ABVC BioPharma, Inc.
|
-2.43 USD
|
76.543%
|
Carisma Therapeutics, Inc.
|
-2.59 USD
|
77.992%
|
Unicycive Therapeutics, Inc.
|
-1.28 USD
|
55.469%
|
OmniAb, Inc.
|
-0.51 USD
|
-11.765%
|
Anew Medical, Inc.
|
0.14 USD
|
507.143%
|
Fennec Pharmaceuticals Inc.
|
-0.60 USD
|
5.0%
|
Lipocine Inc.
|
-3.14 USD
|
81.847%
|
Lexeo Therapeutics, Inc. Common Stock
|
-2.49 USD
|
77.108%
|
Nautilus Biotechnology, Inc.
|
-0.51 USD
|
-11.765%
|
SAB Biotherapeutics, Inc.
|
-7.64 USD
|
92.539%
|
G1 Therapeutics, Inc.
|
-0.93 USD
|
38.71%
|
Bellerophon Therapeutics, Inc.
|
-2.08 USD
|
72.596%
|
Sage Therapeutics, Inc.
|
-9.05 USD
|
93.702%
|
Ocugen, Inc.
|
-0.26 USD
|
-119.231%
|
Mind Medicine (MindMed) Inc.
|
-2.44 USD
|
76.639%
|
Q32 Bio Inc.
|
-35.16 USD
|
98.379%
|
Brainstorm Cell Therapeutics Inc.
|
-0.40 USD
|
-42.5%
|
Alumis Inc. Common Stock
|
-2.99 USD
|
80.936%
|
Equillium, Inc.
|
-0.38 USD
|
-50.0%
|
Kyverna Therapeutics, Inc.
|
-0.00 USD
|
-569900.0%
|
Coya Therapeutics, Inc.
|
-0.79 USD
|
27.848%
|
CNS Pharmaceuticals, Inc.
|
-251.35 USD
|
99.773%
|
Galera Therapeutics, Inc.
|
-1.33 USD
|
57.143%
|
Evelo Biosciences, Inc.
|
-26.28 USD
|
97.831%
|
Comera Life Sciences Holdings, Inc.
|
-1.76 USD
|
67.614%
|
Dominari Holdings Inc.
|
-4.38 USD
|
86.986%
|
Edesa Biotech, Inc.
|
-2.93 USD
|
80.546%
|
vTv Therapeutics Inc.
|
-9.71 USD
|
94.13%
|
Bio-Techne Corporation
|
1.07 USD
|
153.271%
|
Agios Pharmaceuticals, Inc.
|
-6.33 USD
|
90.995%
|
Harmony Biosciences Holdings, Inc.
|
2.17 USD
|
126.267%
|
Prelude Therapeutics Incorporated
|
-2.02 USD
|
71.782%
|
Candel Therapeutics, Inc.
|
-1.31 USD
|
56.489%
|
iTeos Therapeutics, Inc.
|
-3.15 USD
|
81.905%
|
Nkarta, Inc.
|
-2.40 USD
|
76.25%
|
BioCardia, Inc.
|
-8.19 USD
|
93.04%
|
Iterum Therapeutics plc
|
-2.96 USD
|
80.743%
|